Back
Blackbaud, Inc. 10K Form
Buy
68
BLKB
Blackbaud, Inc.
Last Price:
$62.98
Seasonality Move:
-1.02%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | BLKB/Blackbaud, Inc. Quarterly |
| 2024-02-21 | 10K | BLKB/Blackbaud, Inc. Annual |
| 2023-11-01 | 10Q | BLKB/Blackbaud, Inc. Quarterly |
| 2023-08-03 | 10Q | BLKB/Blackbaud, Inc. Quarterly |
| 2023-05-04 | 10Q | BLKB/Blackbaud, Inc. Quarterly |
| 2023-02-24 | 10K | BLKB/Blackbaud, Inc. Annual |
Receive BLKB News And Ratings
See the #1 stock for the next 7 days that we like better than BLKB
BLKB Financial Statistics
Sales & Book Value
| Annual Sales: | $1.2B |
|---|---|
| Cash Flow: | $123.2M |
| Price / Cash Flow: | 13.75 |
| Annual Sales: | $2.25 |
| Price / Book: | 27.28 |
Profitability
| EPS (TTM): | -5.20410 |
|---|---|
| Net Income (TTM): | $-256.2M |
| Gross Margin: | $635.2M |
| Return on Equity: | -139.91% |
| Return on Assets: | -10.74% |
Blackbaud, Inc. Earnings Forecast
Key Blackbaud, Inc. Financial Ratios
-
The Gross Profit Margin over the past 26 years for BLKB is 54.99%.
-
The Selling, General & Administrative Expenses for BLKB have been equal to 29.46% of Gross Profit Margin.
-
The Research & Development expenses have been 13.90% of Revenue.
-
The Net Earning history of BLKB is -24.52% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 11 years.
Blackbaud, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | BLKB |
| CUSIP: | 09227Q |
| Website: | blackbaud.com |
Debt
| Debt-to-Equity Ratio: | 9.9 |
|---|---|
| Current Ratio: | 0.67 |
| Quick Ratio: | 0.59 |
Price-to-Earnings
| Trailing P/E Ratio: | 2365.33 |
|---|---|
| Forward P/E Ratio: | 12.5 |
BLKB Technical Analysis vs Fundamental Analysis
Buy
68
Blackbaud, Inc. (BLKB)
is a Buy
Is Blackbaud, Inc. a Buy or a Sell?
-
Blackbaud, Inc. stock is rated a BuyThe current Blackbaud, Inc. [BLKB] share price is $61.69. The Score for BLKB is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.